Substance Abuse

Substance use disorders appeared to increase excess mortality among patients with eating disorders, according to results of a nationwide register-based retrospective cohort study.

Between 2011 and 2019, fewer than 12% of adolescents with major depression and substance use disorder were treated for both conditions, according to results of a survey study published in JAMA Network Open.

Adverse mental health symptoms and substance use were more prevalent among U.S. adults with disability than those without before and after the COVID-19 pandemic, according to findings published in MMWR.

Preexisting mental disorders, particularly psychotic and mood disorders, as well as exposure to antipsychotics and anxiolytics, increased risk for COVID-19-related mortality.

During the COVID-19 pandemic, requests for smoking-cessation services were down 27%, according to new data from the North American Quitline Consortium.

Children and adolescents who bully their peers have a higher risk for drug, alcohol and tobacco use later in life, according to the results of a meta-analysis published in Pediatrics.

Among veterans, recreational substance use was associated with a higher probability of premature and extremely premature atherosclerotic CVD, and the link was strongest in women, researchers reported in Heart.

The prevalence of adverse mental health symptoms among U.S. adults remained elevated in the later phase of the COVID-19 pandemic vs. prepandemic, according to results of a research letter published in JAMA Network Open.

Combined prevalence estimates of depression, initiating or increasing substance use and suicidal thoughts/ideation among U.S. adults have been significant during the COVID-19 pandemic, researchers noted in MMWR.

The COVID-19 pandemic appeared to shift ED use and priorities for care, particularly related to mental health, substance use and violence risk screening and prevention, according to study results published in JAMA Psychiatry.